SCHEMBL4657690

SCHEMBL4657690

CCC(CC(N)=O)Cc1cccc([N+](=O)[O-])c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.47
CYP2D6 P10635 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
CYP1A2 P05177 1/20 0.45
ALDH1A1 P00352 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
EPHX1 P07099 1/20 0.45
RECQL P46063 1/20 0.44
MAOB P27338 2/20 0.43
MAOA P21397 1/20 0.43
FFAR1 O14842 1/20 0.43
KMO O15229 1/20 0.43
GRM8 O00222 1/20 0.43
GRM6 O15303 1/20 0.43
GRM4 Q14833 1/20 0.43
OPRM1 P35372 1/20 0.42
OPRK1 P41145 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4657090 0.88 FFAR1 (0.52) TSHRCYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL4656396 0.84 ALDH1A1 (0.49) TSHRCYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL4656998 0.81 TSHR (0.53) TSHRALDH1A1L3MBTL1EPHX1KMO
SCHEMBL25955583 0.78 TSHR (0.49) TSHRCYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL30514028 0.78 EPHX1 (0.54) TSHRCYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL4657925 0.77 TSHR (0.48) TSHRCYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL21148837 0.77 EPHX1 (0.47) CYP1A2EPHX1MAOA
SCHEMBL18400704 0.76 TSHR (0.56) TSHRCYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL1205510 0.75 TSHR (0.59) TSHRCYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL2082576 0.75 TSHR (0.59) TSHRALDH1A1EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1295864-B1 PROCESS FOR PREPARATION OF 1,5-DIAMINONAPHTHALENES MITSUI CHEMICALS POLYURETHANES (JP) 2008-12-03 EP disclosed
US-6737548-B2 REACTING AN ORTHO-ALKYLNITROBENZENE WITH VINYL COMPOUND IN PRESENCE OF A BASE TO PRODUCE AN INTERMEDIATE, CYCLIZING THE INTERMEDIATE TO FORM 5-NITRO-1-TETRALONE COMPOUND, THEN REACTING WITH AMINE TO PRODUCE DIAMINONAPHTHALENE COMPOUNDS MITSUI CHEMICALS, INC. (JP) 2004-05-18 US disclosed
US-20030176722-A1 Process for preparation of 1,5-diaminonaphthalenes MITSUI CHEMICALS POLYURETHANES, INC. (JP) 2003-09-18 US disclosed
EP-1295864-A1 PROCESS FOR PREPARATION OF 1,5-DIAMINONAPHTHALENES Mitsui Chemicals, Inc. (JP) 2003-03-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030176722-A1 Process for preparation of 1,5-diaminonaphthalenes NOX5, NOX1, DPYD TSHR 4208/4885CYP2D6 191/4885CYP2C9 357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.